Hematological Malignancies In the News
City of Hope scientists present latest cancer research advances at AACR
Researchers at City of Hope will present a number of new findings at this year’s American Association for Cancer Research Annual Meeting, including a potentially more accurate biomarker for pancreatic cancer, the impact of obesity and a high-fat diet on cancer development, and the link between premature breast tissue "age" and breast cancer.
Brave teenager wins battle against sickle cell anemia
Tyus Munford was diagnosed with sickle cell anemia shortly after birth. After enduring lung damage from the disease, Tyus underwent a bone marrow and then a stem cell transplant at City of Hope. It was a long road, but two years past his procedures, Tyus, now 15, is doing great.
New clinical trial focuses on multiple myeloma precursor in Blacks
A City of Hope clinical trial explores the use of at the rheumatoid arthritis drug leflunomide to treat smoldering multiple myeloma. SMM patients display no symptoms, but are at much higher risk of developing full-blown multiple myeloma, a disease that is twice as common among African Americans.
City of Hope presents leading-edge research on blood cancer therapies and its vaccine to reduce stem cell transplant complications at American Society of Hematology (ASH) Annual Meeting
City of Hope doctors presented data on an investigational bispecific antibody for multiple myeloma and the CMVPepVax, a City of Hope-developed vaccine against the cytomegalovirus, at this year’s ASH Annual Meeting.
Novel immunotherapy produces high rate of lymphoma remission
Data on a bispecific antibody for a form of non-Hodgkin lymphoma was presented at an American Society of Hematology annual meeting press briefing on Dec. 11. Patients within the City of Hope-led trial achieved high response rates, with 80% of patients responding positively to the treatment.
Pivotal study led by City of Hope shows first-in-class cancer immunotherapy achieves high rate of remission in patients with a type of non-Hodgkin lymphoma
Data on bispecific antibody for a non-Hodgkin lymphoma presented today at an American Society of Hematology (ASH) Annual Meeting press briefing.
Surprise viral video star faces cancer diagnosis with positivity
City of Hope Rose Parade float rider Coco Johnson, 17, was diagnosed with a rare bone cancer called Ewing’s sarcoma in 2019. A year later, she was treated for leukemia that developed as a side effect of her chemotherapy regimen. Through it all, she has maintained an upbeat outlook that has garnered her legions of fans.
TV reporter Amanda Salas fought cancer in the public eye
Amanda Salas, entertainment anchor for FOX11’s Good Day L.A. morning show, was in the midst of a banner year for her career, but there were signs that something wasn’t quite right with her health. She learned she had a rare form of non-Hodgkin’s lymphoma.
A firefighter defies predictions and lives in the moment
Matthew Gatewood was in the prime of his life at 39 when concerning results from a physical exam culminated in the shock of a multiple myeloma diagnosis. Worse still, an oncologist offered the grim prognosis that he might live five more years with treatment, two without. That was 2006. Gatewood, captain with the Los Angeles Fire Department, still abides today, thanks to help from City of Hope.